NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung cancer (NSCLC) resections with curative intent, real-world data suggested. The more N1 ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...

Upon IAV infection, lung CD8⁺ tissue-resident memory T (TRM) cells upregulate residency-associated gene signatures but exhibit increased apoptosis. A subset of these cells undergoes CCR5–CCL5 ...

Early-stage non-small cell lung cancer (NSCLC) offers a better prognosis than advanced stages. Staging helps inform treatment by describing your cancer's size, lymph node involvement, and metastasis.

A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors CAMBRIDGE, MA -- Immunotherapy — drug treatment that stimulates the immune system to ...

Doctors typically divide small cell lung cancer (SCLC) into limited or extensive stages, depending on whether the cancer is in one lung, both lungs, or has spread to distant areas. Staging for small ...

Small-cell lung cancer is an invasive cancer that usually affects long-term smokers. It has two stages: limited and extensive. Each stage has a different outlook. Small-cell lung cancer (SCLC) is a ...